Wageningen University Appoints New Professor to Study Cellular Energy and Aging
Wageningen, Wednesday, 23 September 2026.
Professor Werner Koopman has been appointed to a new chair at Wageningen University to research how cellular energy production influences metabolic diseases, aging, and potential therapeutic innovations.
A Convergence of Medicine, Food, and Healthtech
This academic breakthrough sits at the intersection of medicine, food science, and healthtech [1][3]. By investigating how diet, vitamins, and therapeutic interventions influence cellular energy, the newly established chair bridges the gap between nutritional science and clinical medicine [1][3]. The initiative is led by the Executive Board of Wageningen University & Research (WUR), based in Wageningen, Netherlands, which appointed Prof. dr. Werner J.H. Koopman to this special chair starting in September 2026 [1][2]. The position is funded and made possible through a partnership with Radboudumc, an academic medical center based in Nijmegen, Netherlands [1][3]. Koopman, who has a long-standing research history in the Arnhem-Nijmegen area, will operate within WUR’s Human and Animal Physiology group under the leadership of Prof. Jaap Keijer [1][2][3].
The Mechanics of Cellular Powerhouses and the NNT Protein
To understand the mechanics of this research, one must look at mitochondria, which serve as the primary energy generators within animal and human cells [1][3]. Koopman’s research focuses specifically on a mitochondrial protein called nicotinamide nucleotide transhydrogenase (NNT) [1][3]. This protein plays a crucial role in coupling cellular energy production with the mitigation of oxidative stress and metabolic signaling [1][3]. Additionally, the research explores the direct relationship between biochemical reactions and the physical, ultra-structural shape of mitochondria [1]. This includes exploring how thermal interventions affect metabolic rates and even developing artificial mitochondrial structures to study these complex interactions in a controlled environment [1][3].
Targeting Age-Related Diseases and Therapeutic Innovation
The primary benefit of this research lies in its potential to combat aging-related conditions, metabolic disorders, and specific mitochondrial diseases in both humans and animals [1][3]. By understanding how to keep mitochondria healthy through targeted interventions like vitamins and dietary adjustments, researchers can develop preventative therapies [1][3]. This structural and biochemical insight provides the healthtech and pharmaceutical sectors with concrete pathways to design novel drug therapies and metabolic interventions, potentially extending the healthy lifespan of both agricultural livestock and human populations [1][3].